单纯性肾囊肿与腹主动脉瘤腔内修复术后瘤囊缩小的关联
本研究纳入155例接受GORE C3 Excluder行EVAR的肾下型腹主动脉瘤或髂总动脉瘤患者,分为单纯性肾囊肿(SRC)组92例(59.0%)与无SRC组63例(41.0%)。SRC组1年和2年瘤囊缩小比例显著低于无SRC组(19.2% vs 42.4%,P=.003;19.6% vs 53.3%,P=.001)。多变量分析显示SRC是瘤囊缩小的独立危险因素(OR 0.28,95%CI 0.12-0.63,P=.002),提示SRC患者动脉瘤壁退变更重。
要点
- SRC是EVAR术后1年瘤囊缩小的独立危险因素(OR 0.28,95%CI 0.12-0.63,P=.002)。
- SRC组1年瘤囊缩小比例19.2%,显著低于无SRC组的42.4%(P=.003)。
- SRC组2年瘤囊缩小比例19.6%,显著低于无SRC组的53.3%(P=.001)。
核心结论
- SRC的存在是EVAR术后瘤囊缩小失败的危险因素,提示合并SRC的AAA患者动脉瘤壁退变更重。
研究设计与样本
- SRC定义为直径>5 mm、无对比增强或分隔、低衰减的肾脏病灶;瘤囊尺寸较基线变化>5 mm视为显著。
- 患者分为SRC组92例(59.0%)与无SRC组63例(41.0%),比较1年和2年瘤囊缩小情况,并用单变量和多变量logistic回归分析SRC与1年瘤囊缩小失败的关系。
主要发现
- 1年瘤囊缩小比例SRC组19.2% vs 无SRC组42.4%(P=.003),2年19.6% vs 53.3%(P=.001)。
- 1年瘤囊尺寸变化SRC组-2.0±5.5 mm vs 无SRC组-4.4±6.2 mm(P=.002),2年-1.8±6.3 mm vs -6.4±8.6 mm(P=.005)。
- 多变量分析显示SRC(OR 0.28,95%CI 0.12-0.63,P=.002)和初始瘤囊尺寸(OR 1.05,95%CI 1.01-1.09,P=.027)分别为瘤囊缩小的正性和负性危险因素。
关键数值与推荐
- SRC定义:肾脏病灶直径>5 mm,无对比增强或分隔,低衰减。
- 瘤囊尺寸显著变化阈值:较基线>5 mm。
- 瘤囊缩小多变量分析:SRC的OR 0.28(95%CI 0.12-0.63,P=.002);初始瘤囊尺寸的OR 1.05(95%CI 1.01-1.09,P=.027)。
临床怎么用
- 对于合并SRC的AAA患者,EVAR术后应预期瘤囊缩小可能延迟或失败,需加强影像随访。
- SRC可作为评估动脉瘤壁退变程度的潜在影像标志物,辅助术后风险分层。
局限性
- 单中心研究,样本量155例,结论外推需谨慎。
- SRC与瘤囊缩小的关联机制未明确,仅为影像学观察性关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with abdominal aortic aneurysm (AAA) frequently have simple renal cyst (SRC), a common manifestation of connective tissue degeneration. This study aimed to determine whether SRC is a risk factor for failure of sac shrinkage after endovascular aneurysm repair (EVAR). METHODS: Between October 2013 and May 2017, there were 155 consecutive patients with an infrarenal AAA or a common iliac artery aneurysm who underwent EVAR with the GORE C3 Excluder (W. L. Gore & Associates, Flagstaff, Ariz) at Tokyo Medical University Hospital. All these patients were registered in a prospectively maintained database. Any kidney lesion >5 mm in diameter, with no evidence of contrast enhancement or septation and with low attenuation, was defined as SRC. A change in sac size of >5 mm from baseline was considered significant. The patients were divided into those with SRC and those without SRC, and sac shrinkage at 1 year and 2 years was compared. The presence of SRC was assessed with respect to being a risk factor for failure of sac shrinkage at 1 year using univariate and multivariable logistic regression analysis. RESULTS: The patients were divided into two groups: those with SRC (92 patients [59.0%]) and those without SRC (63 patients [41.0%]). At 1 year and 2 years, significant differences were observed in the proportion of sac shrinkage between patients with SRC and those without SRC (19.2% vs 42.4% [P = .003] and 19.6% vs 53.3% [P = .001], respectively). Patients with SRC showed significantly less sac shrinkage than those without SRC at 1 year and 2 years (-2.0 ± 5.5 mm vs -4.4 ± 6.2 mm [P = .002] and -1.8 ± 6.3 mm vs -6.4 ± 8.6 mm [P = .005], respectively). Multivariable analysis demonstrated that SRC (odds ratio, 0.28; 95% confidence interval, 0.12-0.63; P = .002) and initial sac size (odds ratio, 1.05; 95% confidence interval, 1.01-1.09; P = .027) were positive and negative risk factors for sac shrinkage, respectively. CONCLUSIONS: The presence of SRC is a risk factor for failure of sac shrinkage after EVAR. This suggests that AAA in patients with SRC has a more degenerated wall than in those without SRC. The property of the aneurysm wall may be associated with sac shrinkage after EVAR.
引用
- Nishibe T, Dardik A, Koizumi J, et al. Simple renal cyst and its association with sac shrinkage after endovascular aneurysm repair for abdominal aortic aneurysms. J Vasc Surg. 2019. PMID: 31784281. doi:10.1016/j.jvs.2019.05.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。